Literature DB >> 29550289

Penetration in 3D tumor spheroids and explants: Adding a further dimension to the structure-activity relationship of cell-penetrating peptides.

Dirk van den Brand1, Cornelia Veelken2, Leon Massuger3, Roland Brock4.   

Abstract

Drug delivery into tumors and metastases is a major challenge in the eradication of cancers such as epithelial ovarian carcinoma. Cationic cell-penetrating peptides (CPPs) are a promising group of delivery vehicles to mediate cellular entry of molecules that otherwise poorly enter cells. However, little is known about their penetration behavior in tissues. Here, we investigated penetration of cationic CPPs in 3D ovarian cancer spheroids and patient-derived 3D tumor explants. Penetration kinetics and distribution after long-term incubation were imaged by confocal microscopy. In addition, spheroids and tumor explants were dissociated and cell-associated fluorescence determined by flow cytometry. CPPs with high uptake activity showed enhanced sequestration in the periphery of the spheroid, whereas less active CPPs were able to penetrate deeper into the tissue. CPPs consisting of d-amino acids were advantageous over l-amino acid CPPs as they showed less but long lasting cellular uptake activity, which benefitted penetration and retention over time. In primary tumor cultures, in contrast to nonaarginine, the amphipathic CPP penetratin was strongly sequestered by cell debris and matrix components pointing towards arginine-rich CPPs as a preferred choice. Overall, the data show that testing in 3D models leads to a different choice of the preferred peptide in comparison to a standard 2D cell culture.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  3D tumor model; Cell-penetrating peptide; Drug delivery; Ovarian cancer; Tumor explant

Mesh:

Substances:

Year:  2018        PMID: 29550289     DOI: 10.1016/j.bbamem.2018.03.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta Biomembr        ISSN: 0005-2736            Impact factor:   3.747


  4 in total

1.  nurP28, a New-to-Nature Zein-Derived Peptide, Enhances the Therapeutic Effect of Docetaxel in Breast Cancer Monolayers and Spheroids.

Authors:  Plinio Alejandro Trinidad-Calderón; Laura Margarita López-Castillo; Salvador Gallegos-Martínez; Grissel Trujillo-de Santiago; Silverio García-Lara; Mario Moisés Álvarez
Journal:  Molecules       Date:  2022-04-29       Impact factor: 4.927

2.  Boosting cisplatin chemotherapy by nanomotor-enhanced tumor penetration and DNA adducts formation.

Authors:  Lihua Xu; Kaixiang Zhang; Xing Ma; Yingying Li; Yajie Jin; Chenglin Liang; Yong Wang; Wendi Duan; Hongling Zhang; Zhenzhong Zhang; Jinjin Shi; Junjie Liu; Yunlong Wang; Wentao Li
Journal:  J Nanobiotechnology       Date:  2022-09-29       Impact factor: 9.429

3.  Comparing Variants of the Cell-Penetrating Peptide sC18 to Design Peptide-Drug Conjugates.

Authors:  Joshua Grabeck; Tamara Lützenburg; Pia Frommelt; Ines Neundorf
Journal:  Molecules       Date:  2022-10-07       Impact factor: 4.927

4.  CPPs to the Test: Effects on Binding, Uptake and Biodistribution of a Tumor Targeting Nanobody.

Authors:  Estel Collado Camps; Sanne A M van Lith; Cathelijne Frielink; Jordi Lankhof; Ingrid Dijkgraaf; Martin Gotthardt; Roland Brock
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.